Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes

Shkreli must stay mum on pharma after judge upholds lifetime industry ban fkansteiner Mon, 02/07/2022 – 08:43

J&J, plowing ahead with talc bankruptcy strategy, faces investor push to pull product worldwide fkansteiner Mon, 02/07/2022 – […]

Teva forks over $150M to settle Texas opioid suit fkansteiner Mon, 02/07/2022 – 11:33

GSK finds Americans missed 37M routine vaccinations amid pandemic nmissakian Fri, 02/04/2022 – 22:34

Sanofi’s simplified brand opens a fresh chapter as new strategy, pandemic help turn the page badams Mon, 02/07/2022 […]

British general practitioners have been tasked with assisting thousands of recently arrived migrant patients with little knowledge of […]

This paper details guidelines for the content of statistical analysis plans (SAPs) for early phase clinical trials, presenting […]

Scientists believe it may be possible to prevent DNA changes driven by two proteins highly active in leukemia […]

Updated Date: Fri, 28 Jan 2022 00:00:00 EST